BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng Y, Ling Y, Zhang DY, Tan CP, Zhang H, Yang GG, Wang H, Ji LN, Mao ZW. Regulating Tumor N6 -Methyladenosine Methylation Landscape using Hypoxia-Modulating OsSx Nanoparticles. Small 2021;17:e2005086. [PMID: 33284508 DOI: 10.1002/smll.202005086] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang M, Liang Y, Liao F, Younis MR, Zheng Y, Zhao X, Yu X, Guo W, Zhang DY. Iridium Tungstate Nanozyme-Mediated Hypoxic Regulation and Anti-inflammation for Duplex Imaging Guided Photothermal Therapy of Metastatic Breast Tumors. ACS Appl Mater Interfaces 2022;14:56471-82. [PMID: 36519432 DOI: 10.1021/acsami.2c14799] [Reference Citation Analysis]
2 Pan Z, Ling Y, Zhang H, Hao L, Tan C, Mao Z. Pt(IV)-Deferasirox Prodrug Combats DNA Damage Repair by Regulating RNA N 6 -Methyladenosine Methylation. J Med Chem . [DOI: 10.1021/acs.jmedchem.2c01224] [Reference Citation Analysis]
3 Wang MM, Xu FJ, Su Y, Geng Y, Qian XT, Xue XL, Kong YQ, Yu ZH, Liu HK, Su Z. A New Strategy to Fight Metallodrug Resistance: Mitochondria-Relevant Treatment through Mitophagy to Inhibit Metabolic Adaptations of Cancer Cells. Angew Chem Int Ed Engl 2022;61:e202203843. [PMID: 35384194 DOI: 10.1002/anie.202203843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wang M, Xu F, Su Y, Geng Y, Qian X, Xue X, Kong Y, Yu Z, Liu H, Su Z. A New Strategy to Fight Metallodrug Resistance: Mitochondria‐Relevant Treatment through Mitophagy to Inhibit Metabolic Adaptations of Cancer Cells. Angewandte Chemie. [DOI: 10.1002/ange.202203843] [Reference Citation Analysis]
5 Yim G, Kang S, Chae SY, Chung E, Song TK, Park JH, Yoon C, Min DH, Jang H. Precursor Heterogeneity Driven Mo-Te Nanoparticle Structural Diversification for Cancer Photo-Theranostics. ACS Appl Mater Interfaces 2022. [PMID: 35176852 DOI: 10.1021/acsami.1c20634] [Reference Citation Analysis]
6 Su Y, Lin H, Tu Y, Wang M, Zhang G, Yang J, Liu H, Su Z. Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens. Chem Sci 2022;13:1428-39. [DOI: 10.1039/d1sc06722b] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
7 Guan Q, Zhou LL, Dong YB. Ferroptosis in cancer therapeutics: a materials chemistry perspective. J Mater Chem B 2021;9:8906-36. [PMID: 34505861 DOI: 10.1039/d1tb01654g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
8 Huang D, Wang G, Mao J, Liu C, Fan Z, Zhang Y, Zhang B, Zhao Y, Dai C, He Y, Ma H, Liu G, Chen X, Zhao Q. Intravital Whole-Process Monitoring Thermo-Chemotherapy Via 2D Silicon Nanoplatform: A Macro Guidance and Long-Term Microscopic Precise Imaging Strategy. Adv Sci (Weinh) 2021;8:e2101242. [PMID: 34166580 DOI: 10.1002/advs.202101242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]